Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-23-000124

EVP, Quality & Ethics, and CPL acquired 46,155 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Glessner Coleen EVP, Quality & Ethics, and CPL 2023-06-09 Grant or award +15,385 134,579 D: show line 1 in the form
Glessner Coleen EVP, Quality & Ethics, and CPL 2023-06-09 Grant or award +30,770 165,349 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Glessner Coleen EVP, Quality & Ethics, and CPL 2023-06-09 Grant or award · Employee Stock Option (Right to buy) +30,770 62,113 D: show line 3 in the form
Loading xslF345X04/wk-form4_1686705752.xml…